Analytical Data
-
基因名
HM13
- Application
-
别名
dJ324O17.1; H13; hIMP1; Histocompatibility (minor) 13; HM13; HM13_HUMAN; IMP-1; IMP1; IMPAS; IMPAS-1; Intramembrane protease 1; Intramembrane protease; Minor histocompatibility antigen 13; Minor histocompatibility antigen H13; MSTP086; OTTHUMP00000030527; OTTHUMP00000030528; OTTHUMP00000030530; OTTHUMP00000214528; Presenilin-like protein 3; PSENL3; PSL3; Signal peptide peptidase; Signal peptide peptidase beta; SPP
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8TCT9
-
表达区间
1-143aa
-
氨基酸序列
MDSALSDPHNGSAEAGGPTNSTTRPPSTPEGIALAYGSLLLMALLPIFFGALRSVRCARGKNASDMPETITSRDAARFPIIASCTLLGLYLFFKIFSQEYINLLLSMYFFVLGILALSHTIRSEGISLQHLKQLSREPVQGLG
-
分子量
41.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HM13 recombinant protein has garnered significant attention in the field of molecular biology and biochemistry due to its potential applications in therapeutic development and basic research. The HM13 protein, identified from specific microbial sources, exhibits unique structural and functional properties that suggest its involvement in various biological processes, such as immune response modulation and cell signaling. Previous studies have indicated that HM13 may play a role in enhancing the stability and efficacy of therapeutic agents, making it a candidate for drug formulation. Additionally, its ability to interact with specific cellular pathways opens avenues for research into its implications in disease mechanisms, particularly in oncology and infectious diseases. The advent of recombinant DNA technology has facilitated the production and characterization of HM13 in controlled environments, allowing researchers to explore its biological functions, optimize its applications, and assess its potential as a target for novel therapeutics. Understanding the full spectrum of HM13's activities will not only contribute to the advancement of protein engineering but also foster innovations in treatment strategies for various medical conditions. This research holds promise for expanding our knowledge of protein interactions and enhancing therapeutic development.
